| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.51 | $0.86 | $0.83 | $0.72 | $0.67 | $0.44 | — | — |
| EPS (Diluted) | $0.50 | $0.86 | $0.83 | $0.72 | $0.67 | $0.44 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7B | $5.2B | $5.3B | $5.5B | $4.6B | $4.3B | $3.9B | $3.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $2.7B | $2.1B | $2.1B | $2.2B | $1.9B | $1.8B | $2.1B | $1.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.9B | $3.0B | $3.0B | $3.1B | $2.6B | $2.3B | $1.7B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.7B | $-0.1B | $0.0B | $-0.9B | $-0.6B | $-0.1B | $-0.8B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $-0.2B | $-0.3B | $0.6B | $0.3B | $-0.0B | $0.7B | $0.4B |